FRANCISCO JOSE
HERMIDA PRADO
Researcher
Researcher in the period 2022-2024
Publications (36) FRANCISCO JOSE HERMIDA PRADO publications
2025
-
CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancer
Signal Transduction and Targeted Therapy, Vol. 10, Núm. 1
-
Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor–positive breast cancer
JCI Insight , Vol. 10, Núm. 12
-
Tamoxifen induces PI3K activation in uterine cancer
Nature Genetics, Vol. 57, Núm. 9, pp. 2192-2202
2024
-
Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological Grading
International Journal of Molecular Sciences, Vol. 25, Núm. 5
-
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer
npj Breast Cancer, Vol. 10, Núm. 1
-
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 30, Núm. 9, pp. 1889-1905
-
Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis
Journal of translational medicine, Vol. 22, Núm. 1, pp. 135
2023
-
Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics
Biomedicine and Pharmacotherapy, Vol. 158
-
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer
Cancer research, Vol. 83, Núm. 19, pp. 3284-3304
-
Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways
Biomedicine and Pharmacotherapy, Vol. 161
2022
-
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
Cancer research, Vol. 82, Núm. 20, pp. 3673-3686
-
Pathobiological functions and clinical implications of annexin dysregulation in human cancers
Frontiers in Cell and Developmental Biology, Vol. 10
2021
-
The ESR1 Mutations: From Bedside to Bench to Bedside
Cancer Research
-
Tumor-infiltrating cd20+ b lymphocytes: Significance and prognostic implications in oral cancer microenvironment
Cancers, Vol. 13, Núm. 3, pp. 1-16
2020
-
Expression of E-cadherin and β-catenin in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas
Acta Otorrinolaringologica Espanola, Vol. 71, Núm. 6, pp. 358-366
-
Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma
Oral Oncology, Vol. 110
-
Lectin-like transcript 1 (LLT1) checkpoint: A novel independent prognostic factor in HPV-negative oropharyngeal squamous cell carcinoma
Biomedicines, Vol. 8, Núm. 12, pp. 1-14
-
Prognostic significance of the pluripotency factors NANOG, SOX2, and OCT4 in head and neck squamous cell carcinomas
Cancers, Vol. 12, Núm. 7, pp. 1-15
2019
-
Deciphering the molecular basis of melatonin protective effects on breast cells treated with doxorubicin: Twist1 a transcription factor involved in emt and metastasis, a novel target of melatonin
Cancers, Vol. 11, Núm. 7
-
MAPK inhibition and growth hormone: a promising therapy in XLH
FASEB Journal, Vol. 33, Núm. 7, pp. 8349-8362